Abstract
Glucose transporter 1 deficiency syndrome (Glut1-DS) is a congenital metabolic disorder characterized by refractory seizures with early infantile onset, developmental delay, movement disorders and acquired microcephaly. Glut1-DS is caused by heterozygous abnormalities of the SLC2A1 (Glut1) gene, whose product acts to transport glucose into the brain across the blood-brain barrier. We analyzed the SLC2A1 gene in 12 Japanese Glut1-DS patients who were diagnosed by characteristic clinical symptoms and hypoglycorrhachia as follows: all patients had infantile-onset seizures and mild to severe developmental delay, and ataxia was detected in 11 patients. For the 12 patients, we identified seven different mutations (three missense, one nonsense, two frameshift and one splice-site) in exons and exon–intron boundaries of the SLC2A1 gene by direct sequencing, of which six were novel mutations. Of the remaining five patients who had no point mutations and underwent investigation by multiplex ligation-dependent probe amplification, a complex abnormality with deletion and duplication was identified in one patient: this is the first case of such recombination of the SLC2A1 gene. Changes in regulatory sequences in the promoter region or genes other than SLC2A1 might be responsible for onset of Glut1-DS in the other four patients (33%) without SLC2A1 mutation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
De Vivo, D. C., Trifiletti, R. R., Jacobson, R. I., Ronen, G. M., Behmand, R. A. & Harik, S. I. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med. 325, 703–709 (1991).
Shows, T. B., Eddy, R. L., Byers, M. G., Fukushima, Y., Dehaven, C. R., Murray, J. C. et al. Polymorphic human glucose transporter gene (GLUT) is on chromosome 1p31.3--p35. Diabetes. 36, 546–549 (1987).
Fukumoto, H., Seino, S., Imura, H., Seino, Y. & Bell, G. I. Characterization and expression of human HepG2/erythrocyte glucose-transporter gene. Diabetes. 37, 657–661 (1988).
Seidner, G., Alvarez, M. G., Yeh, J. I., O’Driscoll, K. R., Klepper, J., Stump, T. S. et al. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet. 18, 188–191 (1998).
Levy, B., Wang, D., Ullner, P. M., Engelstad, K., Yang, H., Nahum, O. et al. Uncovering microdeletions in patients with severe Glut-1 deficiency syndrome using SNP oligonucleotide microarray analysis. Mol. Genet. Metab. 100, 129–135 (2010).
Klepper, J., Garcia-Alvarez, M., O’Driscoll, K. R., Parides, M. K., Wang, D., Ho, Y. Y. et al. Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome. J. Clin. Lab. Anal. 13, 116–121 (1999).
Tao, T., Tanizawa, Y., Matsutani, A., Matsubara, A., Kaneko, T. & Kaku, K. HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects. Diabetologia. 38, 942–947 (1995).
Schouten, J. P., McElgunn, C. J., Waaijer, R., Zwijnenburg, D., Diepvens, F. & Pals, G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic. Acids. Res. 30, e57 (2002).
Wang, D., Pascual, J. M., Yang, H., Engelstad, K., Jhung, S., Sun, R. P. et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann. Neurol. 57, 111–118 (2005).
Klepper, J. & Leiendecker, B. GLUT1 deficiency syndrome--2007 update. Dev. Med. Child. Neurol. 49, 707–716 (2007).
Zorzi, G., Castellotti, B., Zibordi, F., Gellera, C. & Nardocci, N. Paroxysmal movement disorders in GLUT1 deficiency syndrome. Neurology. 71, 146–148 (2008).
Rotstein, M., Engelstad, K., Yang, H., Wang, D., Levy, B., Chung, W. K. et al. Glut1 deficiency: inheritance pattern determined by haploinsufficiency. Ann. Neurol. 68, 955–958 (2010).
Mullen, S. A., Suls, A., De Jonghe, P., Berkovic, S. F. & Scheffer, I. E. Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology. 75, 432–440 (2010).
De Vivo, D. C. & Wang, D. Glut1 deficiency: CSF glucose. How low is too low? Rev. Neurol. (Paris). 164, 877–880 (2008).
Wang, D., Yang, H., Shi, L., Ma, L., Fujii, T., Engelstad, K. et al. Functional studies of the T295M mutation causing Glut1 deficiency: glucose efflux preferentially affected by T295M. Pediatr. Res. 64, 538–543 (2008).
Leen, W. G., Klepper, J., Verbeek, M. M., Leferink, M., Hofste, T., van Engelen, B. G. et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain. 133, 655–670 (2010).
Haga, H., Yamada, R., Ohnishi, Y., Nakamura, Y. & Tanaka, T. Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. J. Hum. Genet. 47, 605–610 (2002).
Fujii, T., Morimoto, M., Yoshioka, H., Ho, Y. Y., Law, P. P., Wang, D. et al. T295M-associated Glut1 deficiency syndrome with normal erythrocyte 3-OMG uptake. Brain. Dev. 33, 316–320 (2011).
McAllister, M. S., Krizanac-Bengez, L., Macchia, F., Naftalin, R. J., Pedley, K. C., Mayberg, M. R. et al. Mechanisms of glucose transport at the blood-brain barrier: an in vitro study. Brain. Res. 409, 20–30 (2001).
Acknowledgements
This work was supported by Eisai (project no. J109001037) and UCB Japan (project no. J099001110).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hashimoto, N., Kagitani-Shimono, K., Sakai, N. et al. SLC2A1 gene analysis of Japanese patients with glucose transporter 1 deficiency syndrome. J Hum Genet 56, 846–851 (2011). https://doi.org/10.1038/jhg.2011.115
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2011.115
Keywords
This article is cited by
-
Glucose transporters in pancreatic islets
Pflügers Archiv - European Journal of Physiology (2020)
-
Upstream SLC2A1 translation initiation causes GLUT1 deficiency syndrome
European Journal of Human Genetics (2017)
